The Prognostic Significance of Minimal Residual Disease Monitoring by Wt1 Gene Expression in Peripheral Blood Before and after Allogeneic Stem Cell Transplantation in AML Patients

被引：0
|
作者：
Valkova, Veronika [1 ]
Vydra, Jan [1 ]
Markova, Marketa [1 ]
Vitek, Antonin [1 ]
Cerovska, Ela [1 ]
Belickova, Monika [1 ]
Novakova, Ludmila [1 ]
Cemusova, Barbora [1 ]
Koubova, Mariana [1 ]
Cetkovsky, Petr [1 ]
机构：
[1] Inst Hematol & Blood Transfus, Prague, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P028
引用
收藏
页码：203 / 203
页数：1
相关论文
共 50 条
  • [31] Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis
    Valkova, Veronika
    Polak, Jaroslav
    Markova, Marketa
    Vitek, Antonin
    Hajkova, Hana
    Salek, Cyril
    Prochazka, Bohumil
    Cetkovsky, Petr
    Trneny, Marek
    CLINICAL TRANSPLANTATION, 2013, 27 (01) : E21 - E29
  • [32] Clinical implication of minimal residue disease monitoring by WT1 gene detection and flow cytometry in myelodysplastic syndrome with allogeneic stem cell transplantation
    赵晓甦
    China Medical Abstracts (Internal Medicine), 2019, 36 (01) : 56 - 56
  • [33] Allogeneic stem cell transplantation and minimal residual disease in patients with AML in first complete remission
    Versluis, Jurjen
    Cornelissen, Jan J.
    HEMASPHERE, 2018, 2 : 162 - 164
  • [34] Prognostic Significance of Detection of Minimal Residual Disease by Multiparametric Flow Cytometry Before Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
    Panitsas, Fotios P.
    Baltathakis, Ioannis
    Kakkas, Ioannis
    Gigantes, Stavros
    Komitopoulou, Anna
    Oikonomopoulos, Panagiotis
    Tzannou, Ifigeneia
    Grigoriou, Eirini
    Balta, Artemisia
    Vourtsi, Aliki
    Skertsou, Maria
    Apostolidis, John
    Psarra, Aikaterini
    Papasteriades, Chryssa
    Karakassis, Dimitrios
    Harhalakis, Nikolaos
    BLOOD, 2011, 118 (21) : 1759 - 1759
  • [35] Longitudinal follow-up of minimal residual disease in aml after SCT with quantitative evaluation of WT1 gene expression
    Candoni, A.
    Simeone, E.
    D'Odorico, C.
    Toffoletti, E.
    Fanin, R.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S32 - S32
  • [36] Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study
    A M Willasch
    B Gruhn
    T Coliva
    M Kalinova
    G Schneider
    H Kreyenberg
    D Steinbach
    G Weber
    I H I M Hollink
    C M Zwaan
    A Biondi
    V H J van der Velden
    D Reinhardt
    G Cazzaniga
    P Bader
    J Trka
    Leukemia, 2009, 23 : 1472 - 1479
  • [37] Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study
    Willasch, A. M.
    Gruhn, B.
    Coliva, T.
    Kalinova, M.
    Schneider, G.
    Kreyenberg, H.
    Steinbach, D.
    Weber, G.
    Hollink, Ihim
    Zwaan, C. M.
    Biondi, A.
    van der Velden, V. H. J.
    Reinhardt, D.
    Cazzaniga, G.
    Bader, P.
    Trka, J.
    LEUKEMIA, 2009, 23 (08) : 1472 - 1479
  • [38] Longitudinal monitoring of Wilms'Tumor 1 (WT1) expression by a standardized European Leukemia Net (ELN)-certified assay for detection of minimal residual disease (MRD) in MDS patients undergoing allogeneic blood stem cell transplantation
    Rautenberg, C.
    Pechtel, S.
    Hildebrandt, B.
    Betz, B.
    Dienst, A.
    Nachtkamp, K.
    Schmidt, P., V
    Heyn, C.
    Kondakci, M.
    Geyh, S.
    Haas, R.
    Germing, U.
    Kobbe, G.
    Schroeder, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 141 - 141
  • [39] Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression
    Polak, Jaroslav
    Hajkova, Hana
    Maalaufova-Soukupova, Jacqueline
    Markova, Jana
    Salek, Cyril
    Schwarz, Jiri
    Haskovec, Cedrik
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (01) : 129 - 133
  • [40] Prognostic Value of Minimal Residual Disease before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
    Perez-Lopez, Olga
    Caballero-Velazquez, Teresa
    Colado, Enrique
    Alonso, Sara
    Gonzalez-Campos, Jose
    Prats-Martin, Concepcion
    Rodriguez-Torres, Nancy
    Escamilla Gomez, Virginia
    Espigado, Ildefonso
    Antonio Perez-Simon, Jose
    BLOOD, 2018, 132
12345